{"id":27973,"date":"2021-04-08T13:02:26","date_gmt":"2021-04-08T17:02:26","guid":{"rendered":"https:\/\/www.bu.edu\/research\/?p=27973"},"modified":"2021-04-12T08:53:48","modified_gmt":"2021-04-12T12:53:48","slug":"novartis-institutes-for-biomedical-research-global-scholars-program-2021","status":"publish","type":"post","link":"https:\/\/www.bu.edu\/research\/2021\/04\/08\/novartis-institutes-for-biomedical-research-global-scholars-program-2021\/","title":{"rendered":"Novartis Institutes for BioMedical Research Global Scholars Program 2021"},"content":{"rendered":"<p>Novartis Institutes for BioMedical Research (NIBR) have invited Boston University, as one of a select group of international institutions, to participate in their<span>\u00a0<\/span><a href=\"https:\/\/www.bu.edu\/industry\/for-researchers\/nibr-global-scholars-program\/\" target=\"_blank\" rel=\"noopener noreferrer\">NIBR Global Scholars Program 2021<\/a>\u00a0(Kerberos log-in required). The program will provide BU faculty investigators with access to disease area drug-hunting and translational research expertise. Selected proposals, not funded by traditional grant support, will receive up to $1 million over three years.<\/p>\n<p>Initial two-page, non-confidential pre-proposals must be submitted for review by BU Industry Engagement and Technology Development by<span>\u00a0<\/span><strong>Monday, May 10<\/strong>, prior to the NIBR submission (deadline of Friday, May 14). Pre-proposals should be submitted for review using a web form on the<span>\u00a0<\/span><a href=\"https:\/\/www.bu.edu\/industry\/for-researchers\/nibr-global-scholars-program\/\" target=\"_blank\" rel=\"noopener noreferrer\">Industry Engagement website<\/a>\u00a0(Kerberos log-in required).<a href=\"https:\/\/www.bu.edu\/industry\/for-researchers\/nibr-global-scholars-program\/\" target=\"_blank\" rel=\"noopener noreferrer\"><br \/>\n<\/a><\/p>\n<ul><\/ul>\n<p>Proposals focused in any of the following areas are encouraged:<\/p>\n<p><strong>Disease Areas<\/strong><\/p>\n<ul>\n<li>Autoimmunity, Transplantation &amp; Inflammation<\/li>\n<li>Cardiovascular and Metabolic<\/li>\n<li>Immuno-Oncology<\/li>\n<li>Musculoskeletal Diseases<\/li>\n<li>Neurosciences<\/li>\n<li>Oncology<\/li>\n<li>Ophthalmology<\/li>\n<li>Tropical Diseases<\/li>\n<li>Additional Disease Areas<\/li>\n<\/ul>\n<p><strong>Platform Technologies<\/strong><\/p>\n<ul>\n<li>Analytical Sciences &amp; Imaging<\/li>\n<li>Biologics<\/li>\n<li>Cell and Gene Therapy<\/li>\n<li>Chemical and Biological Therapies<\/li>\n<li>Discovery Chemistry<\/li>\n<li>PK Sciences and Preclinical Safety<\/li>\n<\/ul>\n<p>Download the full list of scientific needs on the<span>\u00a0<\/span><a href=\"https:\/\/www.bu.edu\/industry\/files\/__restricted\/entire-bu-community\/NGSP2021_NIBR_SCIENTIFIC_NEEDS_LISTv2.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">program webpage<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>DEADLINE: May 10, 2021. Novartis Institutes for BioMedical Research (NIBR) have invited Boston University to participate in their\u00a0NIBR Global Scholars Program 2021. The program will provide BU faculty investigators with access to disease area drug-hunting and translational research expertise. Selected proposals, not funded by traditional grant support, will receive up to $1 million over three years.<\/p>\n","protected":false},"author":16125,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[225,426],"tags":[],"_links":{"self":[{"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/posts\/27973"}],"collection":[{"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/users\/16125"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/comments?post=27973"}],"version-history":[{"count":2,"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/posts\/27973\/revisions"}],"predecessor-version":[{"id":28023,"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/posts\/27973\/revisions\/28023"}],"wp:attachment":[{"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/media?parent=27973"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/categories?post=27973"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/tags?post=27973"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}